Establishment and Molecular Characterization of an In Vitro Model for PARPi-Resistant Ovarian CancerDaniel Martin Klotz(German Cancer Research Center), Jan Dominik Kuhlmann(German Cancer Research Center)CancersJuly 25, 202310.3390/cancers15153774Cited by 10SaveCiteExport RISWatch citationsRelated PapersThe conjugated antimetabolite 5-FdU-ECyd and its cellular and molecular effects on platinum-sensitive vs. -resistant ovarian cancer cells<i>in vitro</i>|Oncotarget|2017|8